MGCD0103
Term · Oncology and biomedicine · MLC-T-ONC-005342
A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called mocetinostat.
| Identifier | MLC-T-ONC-005342 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | mocetinostat |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-005342",
"term": "MGCD0103",
"field": "Oncology and biomedicine",
"definition": "A substance being studied in the treatment of several types of cancer. It blocks enzymes needed for cell division and may kill cancer cells. It is a type of histone deacetylase (HDAC) inhibitor. Also called mocetinostat.",
"expansions": [
"mocetinostat"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/mgcd0103/"
}
Record 10,984 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.